Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review

References

• World Health Organization Coronavirus disease (COVID-19) pandemic. Available at: https://covid19.who.int/
   Google Scholar
• Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus/types.html
   Google Scholar
• Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389–397.
   PubMed Web of Science ®Google Scholar
• Chan JF, Lau SK, To KK, et al. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28(2):465–522.
   PubMed Web of Science ®Google Scholar
• Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
   PubMed Web of Science ®Google Scholar
• Meena P, Bhargava V, Rana DS, et al. COVID-19 and the kidney: a matter of concern. Curr Med Res Pract. 2020;10(4):165–168.
   PubMedGoogle Scholar
• Rabb H. Kidney diseases in the time of COVID-19: major challenges to patient care. J Clin Invest. 2020;130(6):2749–2751.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 2020;96(1137):403–407.
   PubMed Web of Science ®Google Scholar
• Michaud V, Deodhar M, Arwood M, et al. ACE2 as a therapeutic target for COVID-19; its role in infectious processes and regulation by modulators of the RAAS system. J Clin Med. 2020;9(7):2096.
   Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251–254.
   PubMed Web of Science ®Google Scholar
• Nimkar A, Naaraayan A, Hasan A, et al. Incidence and risk factors for acute kidney injury and its effect on mortality in patients hospitalized from Covid-19. Mayo Clin Proc Innov Qual Outcomes. 2020.DOI:10.1016/j.mayocpiqo.2020.07.003. [online ahead of print].
   PubMedGoogle Scholar
• Panitchote A, Mehkri O, Hastings A, et al. Factors associated with acute kidney injury in acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):74.
   PubMedGoogle Scholar
• Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013; 9(5):255–265.
   PubMed Web of Science ®Google Scholar
• Cohen G. Immune dysfunction in Uremia 2020. Toxins (Basel). 2020;12(7):439.
   Web of Science ®Google Scholar
• Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):8–15.
   PubMed Web of Science ®Google Scholar
• Murad MH, Sultan S, Haffar S, et al. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63.
   PubMedGoogle Scholar
• Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
   PubMed Web of Science ®Google Scholar
• Schunemann HJ. GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice. Z Evid Fortbild Qual Gesundhwes. 2009;103(6):391–400.
   PubMedGoogle Scholar
• Murad MH, Mustafa RA, Schunemann HJ, et al. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85–87.
   PubMedGoogle Scholar
• Atkins D, Eccles M, Flottorp S, et al.; GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004;4(1):38.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802.
   PubMed Web of Science ®Google Scholar
• Luo X, Xia H, Yang W, et al. Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China. medRxiv. 2020.DOI:10.1101/2020.03.19.20033175
   Google Scholar
• Chen M, Fan Y, Wu X, et al. Clinical characteristics and risk factors for fatal outcome in patients with 2019-coronavirus infected disease (COVID-19) in Wuhan, China (2/27/2020). Lancet 2020.
   Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
   PubMed Web of Science ®Google Scholar
• Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020;31(7):1387–1397.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, China Medical Treatment Expert Group for Covid-19, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Cao J, Tu WJ, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):748–755.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.
   PubMed Web of Science ®Google Scholar
• Wang L, Li X, Chen H, et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol. 2020;51(5):343–348.
   PubMed Web of Science ®Google Scholar
• Ma Y, Diao B, Lv X, et al. COVID-19 in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv. 2020. DOI:10.1101/2020.02.24.20027201
   Google Scholar
• Lu H, Ai J, Shen Y, et al. A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention. medRxiv. 2020. DOI:10.1101/2020.02.19.20025031
   Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv. 2020. DOI:10.1101/2020.03.04.20031120
   PubMedGoogle Scholar
• Arslan H, Musabak U, Ayvazoglu Soy EH, et al. Incidence and immunologic analysis of coronavirus disease (COVID-19) in hemodialysis patients: a single-center experience. Exp Clin Transplant. 2020; 18(3):275–283.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97(5):829–838.
   PubMed Web of Science ®Google Scholar
• Jung HY, Lim JH, Kang SH, et al. Outcomes of COVID-19 among patients on in-center hemodialysis: an experience from the epicenter in South Korea. J Clin Med. 2020; 9(6):1688.
   Web of Science ®Google Scholar
• Pei G, Zhang Z, Peng J, et al. Renal Involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157–1165.
   PubMed Web of Science ®Google Scholar
• Goicoechea M, Sanchez Camara LA, Macias N, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020; 98(1):27–34.
   PubMed Web of Science ®Google Scholar
• Dudreuilh C, Kumar N, Moxham V, et al. De-isolation of COVID-19-positive hemodialysis patients in the outpatient setting: a single-center experience. Kidney Int. 2020;98(1):236–237.
   PubMed Web of Science ®Google Scholar
• Manganaro M, Baldovino S, Working group of the P, Aosta Valley Section of the SIN. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol. 2020;33(3):393–395.
   PubMed Web of Science ®Google Scholar
• Albalate M, Arribas P, Torres E, et al. High prevalence of asymptomatic COVID-19 in haemodialysis: learning day by day in the first month of the COVID-19 pandemic. Nefrologia. 2020;40(3):279–286.
   PubMed Web of Science ®Google Scholar
• Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020; 98(1):20–26.
   PubMed Web of Science ®Google Scholar
• Trujillo H, Caravaca-Fontan F, Sevillano A, et al. SARS-CoV-2 infection in hospitalized patients with kidney disease. Kidney Int Rep. 2020;5(6):905–909.
   PubMed Web of Science ®Google Scholar
• Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612.
   PubMed Web of Science ®Google Scholar
• Fisher M, Yunes M, Mokrzycki MH, et al. Chronic hemodialysis patients hospitalized with COVID-19 – short-term outcomes in Bronx, New York. Kidney360. 2020;1(8):755–762.
   PubMedGoogle Scholar
• Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol. 2020; 31(7):1409–1415.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al.; and the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052.
   PubMed Web of Science ®Google Scholar
• Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67(2):698–705.
   PubMed Web of Science ®Google Scholar
• Wong PN, Mak SK, Lo KY, et al. Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients. Am J Kidney Dis. 2003;42(5):1075–1081.
   PubMed Web of Science ®Google Scholar
• Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767–1772.
   PubMed Web of Science ®Google Scholar
• Wu VC, Huang JW, Hsueh PR, et al.; Medicine SRGoNTUCo. National Taiwan University H: Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome. Am J Kidney Dis. 2005;45(1):88–95.
   PubMed Web of Science ®Google Scholar
• Chen LL, Hsu CW, Tian YC, et al. Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. Int J Clin Pract. 2005;59(10):1162–1166.
   PubMed Web of Science ®Google Scholar
• Kwan BC, Leung CB, Szeto CC, et al. Severe acute respiratory syndrome in dialysis patients. J Am Soc Nephrol. 2004;15(7):1883–1888.
   PubMed Web of Science ®Google Scholar
• Farcas GA, Poutanen SM, Mazzulli T, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191(2):193–197.
   PubMed Web of Science ®Google Scholar
• Khalid I, Alraddadi BM, Dairi Y, Khalid TJ, et al. Acute management and long-term survival among subjects with severe Middle East respiratory syndrome coronavirus pneumonia and ARDS. Respir Care. 2016;61(3):340–348.
   PubMed Web of Science ®Google Scholar
• Alfaraj SH, Al-Tawfiq JA, Assiri AY, et al. Clinical predictors of mortality of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: a cohort study. Travel Med Infect Dis. 2019;29:48–50.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Al-Omari A, Mandourah Y, et al. Critically Ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med. 2017;45(10):1683–1695.
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761.
   PubMed Web of Science ®Google Scholar
• Al-Jasser FS, Nouh RM, Youssef RM. Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015. J Infect Public Health. 2019;12(2):171–177.
   PubMed Web of Science ®Google Scholar
• Shalhoub S, Farahat F, Al-Jiffri A, et al. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015; 70(7):2129–2132.
   PubMed Web of Science ®Google Scholar
• Sherbini N, Iskandrani A, Kharaba A, et al. Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data. J Epidemiol Glob Health. 2017;7(1):29–36.
   PubMed Web of Science ®Google Scholar
• Alfaraj SH, Al-Tawfiq JA, Altuwaijri TA, et al. Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia. Front. Med. 2019;13(1):126–130.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Hinedi K, Ghandour J, et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis. 2014;59(2):160–165.
   PubMed Web of Science ®Google Scholar
• Khalid M, Khan B, Al Rabiah F, et al. Middle Eastern respiratory syndrome corona virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia. Ann Saudi Med. 2014;34(5):396–400.
   PubMed Web of Science ®Google Scholar
• Garout MA, Jokhdar HAA, Aljahdali IA, et al. Mortality rate of ICU patients with the Middle east respiratory syndrome – coronavirus infection at King Fahad Hospital, Jeddah, Saudi Arabia. Cent Eur J Public Health. 2018;26(2):87–91.
   PubMed Web of Science ®Google Scholar
• Assiri A, Abedi GR, Bin Saeed AA, et al. Multifacility outbreak of Middle East Respiratory syndrome in Taif, Saudi Arabia. Emerg Infect Dis. 2016;22(1):32–40.
   PubMed Web of Science ®Google Scholar
• Hastings DL, Tokars JI, Abdel Aziz IZ, et al. Outbreak of Middle East respiratory syndrome at tertiary care hospital, Jeddah, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22(5):794–801.
   PubMed Web of Science ®Google Scholar
• Alqahtani FY, Aleanizy FS, Ali El Hadi Mohamed R, et al. Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study. Epidemiol Infect. 2018;147:1–5.
   Web of Science ®Google Scholar
• Omrani AS, Saad MM, Baig K, et al. Albarrak AM: Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14(11):1090–1095.
   PubMed Web of Science ®Google Scholar
• Alanazi KH, Killerby ME, Biggs HM, et al. Scope and extent of healthcare-associated Middle East respiratory syndrome coronavirus transmission during two contemporaneous outbreaks in Riyadh, Saudi Arabia, 2017. Infect Control Hosp Epidemiol. 2019;40(1):79–88.
   PubMed Web of Science ®Google Scholar
• Al Ghamdi M, Alghamdi KM, Ghandoora Y, et al. Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC Infect Dis. 2016;16:174.
   PubMed Web of Science ®Google Scholar
• Cha RH, Joh JS, Jeong I, Critical Care Team of National Medical Center, et al. Critical care team of national medical C: renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci. 2015;30(12):1807–1814.
   PubMed Web of Science ®Google Scholar
• Ng JJ, Luo Y, Phua K, et al. Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): a meta-analysis. J Infect. 2020;81(4):647–679.
   PubMed Web of Science ®Google Scholar
• Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020; 581(7807):221–224.
   PubMed Web of Science ®Google Scholar
• Hui KPY, Cheung MC, Perera R, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8(7):687–695.
   PubMed Web of Science ®Google Scholar
• Behzad S, Aghaghazvini L, Radmard AR, et al. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview. Clin Imaging. 2020;66:35–41.
   PubMed Web of Science ®Google Scholar
• Chen YT, Shao SC, Lai EC, et al. Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis. Crit Care. 2020;24(1):439.
   PubMed Web of Science ®Google Scholar
• Yang X, Jin Y, Li R, et al. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care. 2020;24(1):356.
   PubMed Web of Science ®Google Scholar
• Liu S, Ding X, Cao J, et al. [Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(4):397–400.
   PubMedGoogle Scholar
• El Shamy O, Patel N, Abdelbaset MH, Chenet L, et al. Acute start peritoneal dialysis during the COVID-19 pandemic: outcomes and experiences. J Am Soc Nephrol. 2020;31(8):1680–1682.
   PubMed Web of Science ®Google Scholar
• Swol J, Lorusso R. Additive treatment considerations in COVID-19-The clinician's perspective on extracorporeal adjunctive purification techniques. Artif Organs. 2020;44(9):918–925.
   PubMed Web of Science ®Google Scholar
• Chua HR, MacLaren G, Choong LH, et al. Ensuring sustainability of continuous kidney replacement therapy in the face of extraordinary demand: lessons from the COVID-19 pandemic. Am J Kidney Dis. 2020;76(3):392–400.
   PubMed Web of Science ®Google Scholar
• Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–1994.
   PubMed Web of Science ®Google Scholar
• Fu D, Yang B, Xu J, et al. COVID-19 infection in a patient with end-stage kidney disease. Nephron. 2020;144(5):245–247.
   PubMed Web of Science ®Google Scholar